Literature DB >> 33106914

miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1.

Libing Wang1, Mingxin Cui1, Daming Cheng1, Fengzhi Qu1, Jingkun Yu1, Yanbin Wei2, Ling Cheng2, Xiaotang Wu2, Xiaogang Liu3.   

Abstract

The study aimed to explore the relationship between miR-9-5p and ESR1, and clarify the underlying functional mechanism in the occurrence and development of hepatocellular carcinoma (HCC). Expression data including miRNAs and mRNAs of HCC downloaded from TCGA database were processed for differential analysis, and corresponding clinical data were collected for survival analysis to identify the target miRNA miR-9-5p. Bioinformatics databases were applied for predicting downstream target mRNAs of miR-9-5p. qRT-PCR was used to evaluate expression of miR-9-5p. Western blot was used to detect protein expression of ESR1. MTT, wound healing assay and Transwell assay were used to detect HCC cell proliferation, migration and invasion, respectively. Dual-luciferase reporter gene assay was used to identify the targeting relationship between miR-9-5p and ESR1. Research suggested that miR-9-5p was highly expressed in HCC cells but ESR1 was poorly expressed. Overexpression of miR-9-5p could improve the proliferation, invasion and migration of cells. Dual-luciferase reporter assay showed that ESR1 was the downstream target of miR-9-5p in HCC. Overexpression of miR-9-5p markedly reduced ESR1 mRNA and protein levels in HCC cells, whereas inhibition of miR-9-5p expression produced the contrary results. Silencing ESR1 could noticeably reverse the effect of miR-9-5p knockdown on the proliferation, migration and invasion of HCC cells. As an oncogene, miR-9-5p fostered the proliferation, migration and invasion of HCC cells by targeting and inhibiting ESR1 expression.

Entities:  

Keywords:  ESR1; Hepatocellular carcinoma; Invasion; Migration; Proliferation; miR-9-5p

Mesh:

Substances:

Year:  2020        PMID: 33106914     DOI: 10.1007/s11010-020-03927-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  19 in total

Review 1.  Characteristics of liver cancer stem cells and clinical correlations.

Authors:  Zhuo Cheng; Xiaofeng Li; Jin Ding
Journal:  Cancer Lett       Date:  2015-08-10       Impact factor: 8.679

2.  Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.

Authors:  Dan Han; Jiangxue Li; Huamin Wang; Xiaoping Su; Jin Hou; Yan Gu; Cheng Qian; Yun Lin; Xiang Liu; Mingyan Huang; Nan Li; Weiping Zhou; Yizhi Yu; Xuetao Cao
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

3.  Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.

Authors:  S Azizmohammadi; A Safari; S Azizmohammadi; M Kaghazian; M Sadrkhanlo; E Yahaghi; R Farshgar; M Seifoleslami
Journal:  QJM       Date:  2016-06-26

4.  Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.

Authors:  Chu-Hai Xie; Yan-Ming Cao; Yan Huang; Qun-Wei Shi; Jian-Hong Guo; Zi-Wen Fan; Ju-Gen Li; Bin-Wei Chen; Bo-Yi Wu
Journal:  Tumour Biol       Date:  2016-09-22

5.  MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma.

Authors:  Zhao Sun; Qin Han; Na Zhou; Shihua Wang; Shan Lu; Chunmei Bai; Robert Chunhua Zhao
Journal:  Mol Oncol       Date:  2013-04-25       Impact factor: 6.603

Review 6.  Precision diagnosis and treatment of liver cancer in China.

Authors:  Jing Fu; Hongyang Wang
Journal:  Cancer Lett       Date:  2017-10-16       Impact factor: 8.679

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients.

Authors:  Raffaela Barbano; Barbara Pasculli; Michelina Rendina; Andrea Fontana; Caterina Fusilli; Massimiliano Copetti; Stefano Castellana; Vanna Maria Valori; Maria Morritti; Paolo Graziano; Ciuffreda Luigi; Michelina Coco; Francesco Picardo; Tommaso Mazza; Ella Evron; Roberto Murgo; Evaristo Maiello; Manel Esteller; Vito Michele Fazio; Paola Parrella
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

9.  Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13.

Authors:  Lin Chen; Weifeng Hu; Guohao Li; Yonglian Guo; Zhihua Wan; Jiajun Yu
Journal:  Cell Mol Biol Lett       Date:  2019-03-08       Impact factor: 5.787

10.  Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.

Authors:  Bahareh Nourmohammadi; Elham Tafsiri; Amirabbas Rahimi; Zahra Nourmohammadi; Abolghasem Daneshvar Kakhaki; William Cho; Morteza Karimipoor
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01
View more
  7 in total

1.  Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma.

Authors:  Peng Liu; Bing Han; Yanxia Zhang; Xiaojuan Wang
Journal:  Comput Intell Neurosci       Date:  2022-05-18

2.  hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration.

Authors:  Shengkui Tan; Xin Song; Chenchen Zhang; Yishu Sun; Jiaxi Zhang; Zhongqi Zhang; Rongcheng Zhang; Tianmiao Zhang; Xiaonian Zhu; Hongzhuan Tan
Journal:  J Immunol Res       Date:  2022-05-12       Impact factor: 4.493

3.  miR-9-5p promotes wear-particle-induced osteoclastogenesis through activation of the SIRT1/NF-κB pathway.

Authors:  Liang Zhang; Weidong Zhao; Dongmei Bao; Kening Sun; Peng Li; Zhihui Gao; Zhidong Lu
Journal:  3 Biotech       Date:  2021-05-09       Impact factor: 2.893

4.  Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology.

Authors:  Ho-Sung Lee; In-Hee Lee; Sang-In Park; Minho Jung; Seung Gu Yang; Tae-Wook Kwon; Dae-Yeon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-09       Impact factor: 2.650

5.  Investigating the Role of Dahuang in Hepatoma Treatment Using Network Pharmacology, Molecular Docking, and Survival Analysis.

Authors:  Bin Yu; Maoru Wang; Hui Xu; Rongrong Gao; Yuanying Zhu; Hong Ning; Xiaoyu Dai
Journal:  Biomed Res Int       Date:  2022-07-15       Impact factor: 3.246

6.  Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression.

Authors:  Mara H O'Brien; Henry C Pitot; Sang-Hyuk Chung; Paul F Lambert; Norman R Drinkwater; Andrea Bilger
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

Review 7.  The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma.

Authors:  Yanan Jiang; Xiuyun Shen; Moyondafoluwa Blessing Fasae; Fengnan Zhi; Lu Chai; Yue Ou; Hai Feng; Siwei Liu; Ying Liu; Shucai Yang
Journal:  Oxid Med Cell Longev       Date:  2021-10-16       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.